v3.26.1
TRANSACTIONS AND BALANCES WITH RELATED PARTIES
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Transactions And Balances With Related Parties [Line Items]    
TRANSACTIONS AND BALANCES WITH RELATED PARTIES
NOTE 10  - TRANSACTIONS AND BALANCES WITH RELATED PARTIES:
 
Transactions with related parties which are shareholders and directors of the Company:
 
  a.
Transactions:
 
   
March 31
  
   
2026
    
2025
  
Share-based compensation included in research and development expenses
  
$
130
    
$
-
  
Share-based compensation included in general and administrative expenses
  
$
215
    
$
21
  
Financial expenses
  
$
(15
)
  
$
32
  
 
  b.
Balances:
 
   
March 31,
2026
    
December 31,
2025
  
Current liabilities —
            
Private warrants to purchase ordinary shares
  
$
*
    
$
*
  
Sponsor Promissory Note
  
$
1,553
    
$
-
  
 
   
March 31,
2026
    
December 31,
2025
  
Non-Current liabilities —
            
Sponsor Promissory Note
  
$
-
    
$
1,568
  
NOTE 14  - TRANSACTIONS AND BALANCES WITH RELATED PARTIES:
 
Transactions with related parties— shareholders, executive officers and directors of the Company (including Silexion Israel)—are quantified below:
 
  a.
Transactions:
 
   
Year ended December 31
  
   
2025
    
2024
  
Share-based compensation included in research and development expenses
  
$
-
    
$
1,796
  
Share-based compensation included in general and administrative expenses
  
$
134
    
$
2,972
  
Financial expenses (income)
  
$
232
    
$
(1,249
)
 
  b.
Balances:
 
   
December 31
  
   
2025
    
2024
  
Non-Current liabilities
            
Private warrants to purchase ordinary shares
    
*
    
$
1
  
Sponsor Promissory Note
  
$
1,568
    
$
2,961
  
   
$
1,568
    
$
2,962